Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with an inhibitory concentration (IC50) of 10.02 μM. This compound demonstrates potential utility in the field of neurodegenerative disease research [1].
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 16,000 | |||
10 mg | 在庫あり | ¥ 25,000 | |||
25 mg | 在庫あり | ¥ 52,500 | |||
50 mg | 在庫あり | ¥ 85,000 | |||
100 mg | 在庫あり | ¥ 136,000 | |||
500 mg | 在庫あり | ¥ 289,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
説明 | GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with an inhibitory concentration (IC50) of 10.02 μM. This compound demonstrates potential utility in the field of neurodegenerative disease research [1]. |
ターゲット&IC50 | GSK-3β:10.02 μM |
分子量 | 393.42 |
分子式 | C20H15N3O4S |
CAS No. | 536731-65-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.93 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3β inhibitor 11 536731-65-4 PI3K/Akt/mTOR signaling Stem Cells GSK-3 Inhibitor inhibitor inhibit